Lucira Health Developed Molecular Diagnostic Tests For At Home And Point Of Care Usethe Company Gained Attention For Its Luciraacovid 19 & Flu Testwhich Was The First Fda Authorized At Home Molecular Test Capable Of Distinguishing Between Sars Cov 2Influenza Aand Influenza B Using A Single Nasal Swabadditionallylucira Offered The Lucira Check It Covid 19 Test Kit For At Home Covid 19 Detection And A Combination Covid 19 Flu Test For Clinical Settings Utilizing Loop Mediated Isothermal Amplificationlamptechnologylucira S Tests Provided Rapidlab Quality Resultswith The Covid 19 Flu Test Delivering Results In Just 30 Minutesthe Company Targeted Both Consumers For Direct To Consumer Sales And Healthcare Providers For Point Of Care Testing In Clinics And Hospitals
No conferences found for this company.
| Company Name | Lucira Health Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
